FindMeCure, founded in 2015, is a pioneering company in the Health Care industry headquartered in the United Kingdom. With the slogan "Bringing research closer to patients," the company is on a mission to bridge the gap between clinical research and patient care.
The company's core offerings include a clinical trial search platform that has amassed a global user base of nearly a million. Recognizing inefficiencies in study planning, FindMeCure introduced TrialHub to revolutionize clinical trial feasibility studies. TrialHub aggregates real-time data from 80,000 sources to deliver comprehensive insights for sponsors and CROs, facilitating better recruitment strategies and efficient budgeting.
Notably, TrialHub for Standard of Care offers an unprecedented mapping of patient care standards, connecting reimbursed drugs to indications with 98% accuracy. The company attracted Seed Round investment on January 5, 2023, from a consortium of investors, including Techstars and MFG Invest, highlighting its robust potential for future growth.